BACKGROUND: In diabetic adults, tight control of risk factors reduces complications. OBJECTIVE: To determine whether failure to make visits, monitor risk factors, or intensify therapy affects control of blood pressure, glucose, and lipids. DESIGN: A non-concurrent, prospective study of data from electronic files and standardized abstraction of hard-copy medical records for the period 1/1/1999-12/31/2001. PARTICIPANTS: Three hundred eighty-three adults with diabetes managed in an academically affiliated managed care program. MEASUREMENTS: Main exposure variable: Intensification of therapy or failure to intensify, reckoned on a quarterly basis. MAIN OUTCOME MEASURE: Hemoglobin A1c (A1c), systolic blood pressure (SBP), and LDL-cholesterol at the end of the interval. RESULTS: In this visit-adherent cohort, control of glycemia and lipids showed improvement over 24 months, but many patients did not achieve targets. Only those with the worst blood pressure control (SBP >or=160 mmHg) showed any improvement over 2 years. Failure to intensify treatment in patients who kept visits was the single strongest predictor of sub-optimal control. Compared to their counterparts with no failures of intensification, patients with failures in >or=3 quarters showed markedly worse control of blood glucose (A1c 1.4% higher: 95% CI: 0.7, 2.1); hypertension (SBP 22.2 mmHg higher: 95% CI: 16.6, 27.9) and LDL cholesterol (LDL 43.7 mg/dl higher: 95% CI: 24.1, 63.3). These relationships were strong, graded, and independent of socio-demographic factors, baseline risk factor values, and co-morbidities. CONCLUSIONS: Failure to intensify therapy leads to suboptimal control, even with adequate visits and monitoring. Interventions designed to promote appropriate intensification should enhance diabetes care in primary practice.
BACKGROUND: In diabetic adults, tight control of risk factors reduces complications. OBJECTIVE: To determine whether failure to make visits, monitor risk factors, or intensify therapy affects control of blood pressure, glucose, and lipids. DESIGN: A non-concurrent, prospective study of data from electronic files and standardized abstraction of hard-copy medical records for the period 1/1/1999-12/31/2001. PARTICIPANTS: Three hundred eighty-three adults with diabetes managed in an academically affiliated managed care program. MEASUREMENTS: Main exposure variable: Intensification of therapy or failure to intensify, reckoned on a quarterly basis. MAIN OUTCOME MEASURE: Hemoglobin A1c (A1c), systolic blood pressure (SBP), and LDL-cholesterol at the end of the interval. RESULTS: In this visit-adherent cohort, control of glycemia and lipids showed improvement over 24 months, but many patients did not achieve targets. Only those with the worst blood pressure control (SBP >or=160 mmHg) showed any improvement over 2 years. Failure to intensify treatment in patients who kept visits was the single strongest predictor of sub-optimal control. Compared to their counterparts with no failures of intensification, patients with failures in >or=3 quarters showed markedly worse control of blood glucose (A1c 1.4% higher: 95% CI: 0.7, 2.1); hypertension (SBP 22.2 mmHg higher: 95% CI: 16.6, 27.9) and LDL cholesterol (LDL 43.7 mg/dl higher: 95% CI: 24.1, 63.3). These relationships were strong, graded, and independent of socio-demographic factors, baseline risk factor values, and co-morbidities. CONCLUSIONS: Failure to intensify therapy leads to suboptimal control, even with adequate visits and monitoring. Interventions designed to promote appropriate intensification should enhance diabetes care in primary practice.
Authors: D R Berlowitz; A S Ash; E C Hickey; R H Friedman; M Glickman; B Kader; M A Moskowitz Journal: N Engl J Med Date: 1998-12-31 Impact factor: 91.245
Authors: Richard W Grant; Enrico Cagliero; Patricia Murphy-Sheehy; Daniel E Singer; David M Nathan; James B Meigs Journal: Am J Med Date: 2002-06-01 Impact factor: 4.965
Authors: Andrew J Karter; Melissa M Parker; Howard H Moffet; Ameena T Ahmed; Assiamira Ferrara; Jennifer Y Liu; Joe V Selby Journal: Med Care Date: 2004-02 Impact factor: 2.983
Authors: Julie A Schmittdiel; Connie S Uratsu; Andrew J Karter; Michele Heisler; Usha Subramanian; Carol M Mangione; Joe V Selby Journal: J Gen Intern Med Date: 2008-03-04 Impact factor: 5.128
Authors: Howard H Moffet; Melissa M Parker; Urmimala Sarkar; Dean Schillinger; Alicia Fernandez; Nancy E Adler; Alyce S Adams; Andrew J Karter Journal: Am J Manag Care Date: 2011-05 Impact factor: 2.229
Authors: R Neal Axon; Mulugeta Gebregziabher; Carrae Echols; Gregory Gilbert Msph; Leonard E Egede Journal: J Gen Intern Med Date: 2011-06-14 Impact factor: 5.128
Authors: Suzanne Murray; Patrice Lazure; Sara Schroter; Philipp J Leuschner; Peter Posel; Thomas Kellner; Richard D Jenkins Journal: BMC Fam Pract Date: 2011-05-11 Impact factor: 2.497
Authors: Ning Peng; Jeevan K Prasain; Yanying Dai; Ray Moore; Alireza Arabshahi; Stephen Barnes; Scott Carlson; J Michael Wyss Journal: J Agric Food Chem Date: 2009-08-26 Impact factor: 5.279
Authors: Michele Heisler; Timothy P Hofer; Julie A Schmittdiel; Joe V Selby; Mandi L Klamerus; Hayden B Bosworth; Martin Bermann; Eve A Kerr Journal: Circulation Date: 2012-05-08 Impact factor: 29.690
Authors: Lynn A Nuti; Mark Lawley; Ayten Turkcan; Zhiyi Tian; Lingsong Zhang; Karen Chang; Deanna R Willis; Laura P Sands Journal: BMC Health Serv Res Date: 2012-09-06 Impact factor: 2.655